2006.Center for Disease Control and Prevention (CDC) Hepatocellular carcinoma-United States 2001-, 1 2 3 4 5 6 7 8 9 10 11 -
MMWR Morb Mortal Wkly Rep, 2010., 59 517 -20
BruixJ,ShermanM. AASLD, 2018.Practice Guidelines: management of hepatocellular carcinoma: an update,Hepatology 1 -35
1994.International Agency for Research on Cancer (IARC) Monographs on the evaluation of carcinogenic risks to humans,Hepatitis Viruses 59 3 -55
SohalDP,SunW., 2011.Hepatocellular carcinoma: prevention and therapy,Curr Oncol Rep 13 186 -94
AshamEH,KasebA,GhobrialRM, 2013.Management of hepatocellular carcinoma,Surg Clin North Am (9 1423 -50
LokAS,SeeffLB, 2009.Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease,Gastroenterology 136 138 -48
ButtAS,HamidS,WadalawalaA A,McGlynn KA,LondonWT, 2013.The global epidemiology of hepatocellular carcinoma: present and future,BioMed Central Research Notes 6 11 -
2011.,Clinics in Liver Disease 15 223 -43
2007.Cancer Incidence in Five Continents, Volumes I to IX, 9 -
MonsourHP,AshamE,McFaddenRS,VictorDW,MuthuswamyB,ZaheerI., 2013.Hepatocellular carcinoma: the rising tide from east to west - a review of epidemiology, screening and tumor markers,Transl Cancer Res 2 492 -506
Lencioni R.,LinSM,LinCJ,LinCC, 2005.Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less,Gut 54 1151 -6
WakaiT,ShiraiY,SakataJ,KoritaPV,AjiokaY,HatakeyamaK., 2011.Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease,J Gastrointest Surg 15 1450 -8
2010., 1 -25
LencioniRA,AllgaierHP,CioniD, 2003.Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection,Radiology 228 235 -40
TaniguchiM., 2012.Liver transplantation in the MELD era: Analysis of the OPTN/UNOS registry,ClinTranspl 41 -65
VibertE,AzoulayD,HotiE, 2010.Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor,Am J Transplant 10 129 -37
YaoFY,KerlanRK, 2008.Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis,Hepatology 48 819 -27
RavaioliM,GraziGL,PiscagliaF, 2008.Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria,Am J Transplant 8 2547 -57
PomfretEA,WashburnK,WaldC, 2010.Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States,Liver Transpl 16 262 -78
TosoC,MenthaG,KnetemanNM, 2010.The place of downstaging for hepatocellular carcinoma,J Hepatol 52 930 -6
BhooriS,SpositoC, 2010.Germini A. The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis,Transpl Int 23 712 -22
LlovetJM,BruixJ, 2003.Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival,Hepatology 37 429 -42
LewandowskiRJ,KulikLM, 2009.Riaz A. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization,Am J Transplant 9 1920 -28
SangroB,CarpaneseL,CianniR, 2011.Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation,Hepatology 54 868 -78
CammàC,SchepisF,OrlandoA, 2002.Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials,Radiology 224 47 -54
LammerJ,MalagariK,VoglT. PRECISION V,Investigators, 2010.Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study,Cardiovasc Intervent Radiol 33 41 -52
NicoliniA,MartinettiL,CrespiS,MaggioniM,SangiovanniA, 2010.Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma,J Vasc Interv Radiol 21 327 -32
SangroB,CarpaneseL,CianniR, 2011.Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation,Hepatology 54 868 -78
TrevisaniF,SantiV,GramenziA, 2007.Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?,Am J Gastroenterol 102 2248 -57
PetersonMS,BaronRL, 2001.Radiological diagnosis of hepatocellular carcinoma,Clin Liver Dis 5 123 -44
SiegelAB,CohenEI,OceanA, 2008.Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma,J Clin Oncol 26 2298 -2992
CervelloM., 2012.Targeted therapy for hepatocellular carcinoma: novel agents on the horizon,Onco target 3 236 -60
CollierJ,ShermanM, 1998.Screening for hepatocellular carcinoma,Hepatology 27 273 -8
2018.Sensitivity of diffusion weighted images in detection of small Hepatocellular carcinoma in patients with cirrhosis liver,J Med Sci 26 120 -22